Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Literature DB >> 15557666

Acellular pertussis vaccines and complement killing of Bordetella pertussis.

Alison A Weiss¹, Angela K Patton, Scott H Millen, Swei-Ju Chang, Joel I Ward, David I Bernstein.

Abstract

Antibody-dependent complement killing of Bordetella pertussis after immunization with a three-component acellular pertussis vaccine was characterized. Postimmunization activity was unchanged for about half of the adult vaccine recipients. The responses of the other individuals were complex, with evidence of both beneficial and antagonistic responses occurring, sometimes in the same individual.

Mesh：

Substances：

Year: 2004 PMID： 15557666 PMCID： PMC529164 DOI： 10.1128/IAI.72.12.7346-7351.2004

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

21 in total

1. BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition.

Authors: M G Barnes; A A Weiss
Journal: Infect Immun Date: 2001-05 Impact factor: 3.441

2. Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.

Authors: R Latif; N Kerlero de Rosbo; T Amarant; R Rappuoli; G Sappler; A Ben-Nun
Journal: Infect Immun Date: 2001-05 Impact factor: 3.441

3. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination.

Authors: A S El-Madhun; R J Cox; L R Haaheim
Journal: J Infect Dis Date: 1999-10 Impact factor: 5.226

4. Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin from Bordetella pertussis.

Authors: P McGuirk; K H Mills
Journal: Eur J Immunol Date: 2000-02 Impact factor: 5.532

5. Characterization of bactericidal immune responses following vaccination with acellular pertussis vaccines in adults.

Authors: C L Weingart; W A Keitel; K M Edwards; A A Weiss
Journal: Infect Immun Date: 2000-12 Impact factor: 3.441

6. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.

Authors: J Storsaeter; H O Hallander; L Gustafsson; P Olin
Journal: Vaccine Date: 1998-12 Impact factor: 3.641

7. Serum resistance in bvg-regulated mutants of Bordetella pertussis.

Authors: R C Fernandez; A A Weiss
Journal: FEMS Microbiol Lett Date: 1998-06-01 Impact factor: 2.742

8. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens.

Authors: F Lynn; G F Reed; B D Meade
Journal: Clin Diagn Lab Immunol Date: 1996-11

9. Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.

Authors: T Abramson; H Kedem; D A Relman
Journal: Infect Immun Date: 2001-04 Impact factor: 3.441

10. Characterization of human bactericidal antibodies to Bordetella pertussis.

Authors: A A Weiss; P S Mobberley; R C Fernandez; C M Mink
Journal: Infect Immun Date: 1999-03 Impact factor: 3.441

15 in total

1. Opsonophagocytic activity and other serological indications of Bordetella pertussis infection in military recruits in Norway.

Authors: Audun Aase; Tove Karin Herstad; Samuel Merino; Kari Torkildsen Brandsdal; Bjørn Peter Berdal; Erja M Aleksandersen; Ingeborg S Aaberge
Journal: Clin Vaccine Immunol Date: 2007-05-16

Review 2. What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing.

Authors: Dimitri A Diavatopoulos; Kathryn Margaret Edwards
Journal: Cold Spring Harb Perspect Biol Date: 2017-12-01 Impact factor: 10.005

3. Antibody responses to Bordetella bronchiseptica in vaccinated and infected dogs.

Authors: John Ellis; Carrie Rhodes; Stacey Lacoste; Steven Krakowka
Journal: Can Vet J Date: 2014-09 Impact factor: 1.008

4. Toward a new vaccine for pertussis.

Authors: John B Robbins; Rachel Schneerson; Joanna Kubler-Kielb; Jerry M Keith; Birger Trollfors; Evgeny Vinogradov; Joseph Shiloach
Journal: Proc Natl Acad Sci U S A Date: 2014-02-20 Impact factor: 11.205

5. Differential in vitro expression of the brkA gene in Bordetella pertussis and Bordetella parapertussis clinical isolates.

Authors: Paola Stefanelli; Maurizio Sanguinetti; Cecilia Fazio; Brunella Posteraro; Giovanni Fadda; Paola Mastrantonio
Journal: J Clin Microbiol Date: 2006-09 Impact factor: 5.948

6. Structure and Immunogenicity of the Bordetella pertussis LOS-Derived Oligosaccharides in the Endosomal-Like Pre-Processing Mice Model.

Authors: Sabina Koj; Karolina Ucieklak; Czeslaw Lugowski; Tomasz Niedziela
Journal: Vaccines (Basel) Date: 2021-06-13

7. Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function.

Authors: Scott H Millen; Mineo Watanabe; Eiji Komatsu; Fuminori Yamaguchi; Yuki Nagasawa; Eri Suzuki; Haleigh Monaco; Alison A Weiss
Journal: PLoS One Date: 2015-09-16 Impact factor: 3.240

8. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.

Authors: Davide Valentini; Giovanni Ferrara; Reza Advani; Hans O Hallander; Markus J Maeurer
Journal: BMC Immunol Date: 2015-07-01 Impact factor: 3.615

9. Bordetella pertussis isolates vary in their interactions with human complement components.

Authors: Charlotte Brookes; Irene Freire-Martin; Breeze Cavell; Frances Alexander; Stephen Taylor; Ruby Persaud; Norman Fry; Andrew Preston; Dimitri Diavatopoulos; Andrew Gorringe
Journal: Emerg Microbes Infect Date: 2018-05-09 Impact factor: 7.163

10. Pertussis: challenges today and for the future.

Authors: James D Cherry
Journal: PLoS Pathog Date: 2013-07-25 Impact factor: 6.823